Since the nuclear protein Ki-67 is highly expressed in all active phases of the cell cycle (G1, S, G2, M) but not in quiescent cells (G0), it is widely used as a marker for proliferative activity in cancer types, such as breast cancer (68, 69) and gliomas (70, 71). This evidence concerns the gene MKI67 and glioma.